PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Applied DNA Sciences, Inc. (APDN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS03815U3005
CUSIP03815U300
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$2.98M
EPS-$11.00
Revenue (TTM)$9.00M
Gross Profit (TTM)$5.05M
EBITDA (TTM)-$12.20M
Year Range$3.11 - $37.20
Target Price$45.00
Short %4.58%
Short Ratio1.52

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Applied DNA Sciences, Inc.

Popular comparisons: APDN vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Applied DNA Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%December2024FebruaryMarchAprilMay
-99.91%
370.77%
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Applied DNA Sciences, Inc. had a return of -77.71% year-to-date (YTD) and -88.04% in the last 12 months. Over the past 10 years, Applied DNA Sciences, Inc. had an annualized return of -53.52%, while the S&P 500 had an annualized return of 10.90%, indicating that Applied DNA Sciences, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-77.71%11.05%
1 month-60.06%4.86%
6 months-83.67%17.50%
1 year-88.04%27.37%
5 years (annualized)-63.95%13.14%
10 years (annualized)-53.52%10.90%

Monthly Returns

The table below presents the monthly returns of APDN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-6.37%0.66%-29.47%-51.22%-77.71%
2023-10.84%-5.41%-19.29%-14.16%13.40%17.27%35.66%-26.86%-5.47%-38.02%17.33%-29.91%-62.84%
2022-17.91%-22.42%-16.41%-25.23%-19.38%-42.78%-3.87%339.68%-63.78%57.52%-23.60%22.06%-58.71%
2021118.43%-19.66%-19.66%-4.45%-15.72%17.27%-20.77%8.92%-8.02%-0.19%7.43%-30.45%-21.18%
2020-9.55%5.28%0.75%71.14%41.28%-16.98%23.92%-26.70%5.46%-0.26%-2.46%-32.18%21.72%
201910.78%51.95%5.82%-17.18%-0.54%-14.81%-40.36%2.28%-26.72%-22.58%-39.61%0.24%-73.81%
2018-4.40%-4.61%-0.69%4.86%-1.32%-15.44%9.52%-11.59%22.13%-26.17%0.00%-63.64%-74.84%
2017-2.70%2.78%-10.81%6.06%-25.71%35.38%-1.70%19.65%38.65%-25.78%9.86%-32.05%-14.05%
2016-1.23%-10.31%19.86%-12.50%-2.66%10.24%6.19%-6.71%-4.69%-8.20%-21.43%-15.91%-42.90%
201519.03%13.08%-33.42%2.70%-2.63%19.69%-15.81%36.78%43.42%-32.81%-12.79%8.00%12.11%
2014-12.29%-1.82%-10.06%-8.73%4.26%1.83%-5.81%-4.35%-17.27%9.71%-61.60%25.65%-70.40%
20135.71%-40.32%72.83%-2.01%-5.08%-6.10%-23.95%-14.53%-30.77%46.67%-12.12%40.26%-22.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APDN is 3, indicating that it is in the bottom 3% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of APDN is 33
APDN (Applied DNA Sciences, Inc.)
The Sharpe Ratio Rank of APDN is 55Sharpe Ratio Rank
The Sortino Ratio Rank of APDN is 11Sortino Ratio Rank
The Omega Ratio Rank of APDN is 33Omega Ratio Rank
The Calmar Ratio Rank of APDN is 44Calmar Ratio Rank
The Martin Ratio Rank of APDN is 33Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Applied DNA Sciences, Inc. (APDN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


APDN
Sharpe ratio
The chart of Sharpe ratio for APDN, currently valued at -0.92, compared to the broader market-2.00-1.000.001.002.003.004.00-0.92
Sortino ratio
The chart of Sortino ratio for APDN, currently valued at -2.31, compared to the broader market-4.00-2.000.002.004.006.00-2.31
Omega ratio
The chart of Omega ratio for APDN, currently valued at 0.73, compared to the broader market0.501.001.502.000.73
Calmar ratio
The chart of Calmar ratio for APDN, currently valued at -0.88, compared to the broader market0.002.004.006.00-0.88
Martin ratio
The chart of Martin ratio for APDN, currently valued at -1.59, compared to the broader market-10.000.0010.0020.0030.00-1.59
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-2.00-1.000.001.002.003.004.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.001.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.03, compared to the broader market0.002.004.006.002.03
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.57, compared to the broader market-10.000.0010.0020.0030.009.57

Sharpe Ratio

The current Applied DNA Sciences, Inc. Sharpe ratio is -0.92. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Applied DNA Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.92
2.49
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Applied DNA Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-100.00%
-0.21%
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Applied DNA Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Applied DNA Sciences, Inc. was 100.00%, occurring on May 16, 2024. The portfolio has not yet recovered.

The current Applied DNA Sciences, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Dec 23, 19995343May 16, 2024
-97.92%Jun 30, 19995Nov 4, 19991Nov 12, 19996
-85%Dec 9, 19991Dec 9, 19991Dec 10, 19992

Volatility

Volatility Chart

The current Applied DNA Sciences, Inc. volatility is 32.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2024FebruaryMarchAprilMay
32.57%
3.40%
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Applied DNA Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items